Ocular Therapeutix OCUL
NASDAQ OCUL
$6.96 -0.33 (-4.53%)
At close: Oct 2, 2026 · 4:00 PM EDT

Ocular Therapeutix (OCUL) Return on Assets [ROA] (2014 - 2026)

Updated

Ocular Therapeutix (OCUL) reported Return on Assets [ROA] of -43.13% for Q2 2026, up 8.86 percentage points from -51.99% a year earlier but down 5.42 percentage points from the prior quarter.

Analysis

Ocular Therapeutix (OCUL) Return on Assets [ROA] (2014 - 2026) Analysis & Trends

For FY2025, Ocular Therapeutix posted Return on Assets [ROA] of -41.63%, up 4.87 percentage points from FY2024.

  • Return on Assets [ROA] has a five-year change of -0.85 percentage points (FY2020 to FY2025).
  • By year, Return on Assets [ROA] came in at -46.50% in FY2024 (-1.78 pp), -44.72% in FY2023 (+3.21 pp), -47.93% in FY2022 (-11.65 pp) and -36.28% in FY2021 (+4.50 pp).
  • Five-year quarterly Return on Assets [ROA] spans a low of -71.20% in Q2 2023 and a high of -22.10% in Q2 2024.
  • Year over year, Return on Assets [ROA] gained in four of the last eight quarters, with an average year-over-year change of -3.71 percentage points.
  • The high point for year-over-year Return on Assets [ROA] in five years was Q2 2024 (a gain of 49.11 percentage points); the low point was Q2 2025 (a drop of 29.90 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at -37.71% (Q1 2026), -43.23% (Q4 2025) and -57.35% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 20.64%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 10.47%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 4.65%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.45%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 28.37%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.10%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 9.29%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -6.13%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.14%
10 Ocular Therapeutix 1.53 Bn 1.53 Bn 11.46 Mn -43.13%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -43.13%
Mar 31, 2026 -37.71%
Dec 31, 2025 -43.23%
Sep 30, 2025 -57.35%
Jun 30, 2025 -51.99%
Mar 31, 2025 -45.47%
Dec 31, 2024 -34.81%
Sep 30, 2024 -27.56%
Jun 30, 2024 -22.10%
Mar 31, 2024 -24.71%
Dec 31, 2023 -43.30%
Sep 30, 2023 -61.61%
Jun 30, 2023 -71.20%
Mar 31, 2023 -64.16%
Dec 31, 2022 -55.14%
Sep 30, 2022 -50.54%
Jun 30, 2022 -45.43%
Mar 31, 2022 -41.92%
Dec 31, 2021 -40.07%
Sep 30, 2021 -36.13%
API Access

Ocular Therapeutix Return on Assets [ROA] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=OCUL&period=max&api_key=YOUR_API_KEY